REMUSPharmaceuticals
Remus Pharmaceuticals Ltd — PE Ratio & Valuation Analysis
₹627.90
-9.48%
Current P/E25.09xPrice to earnings
Industry P/E31.77xSector average
✅
21.0% Discount to Industry
REMUS P/E 25.09x vs sector avg 31.77x
💡
Understanding Remus Pharmaceuticals Ltd Valuation
Remus Pharmaceuticals Ltd (REMUS) currently trades at 25.09x earnings. The Pharmaceuticals sector average PE is 31.77x. REMUS is trading at a discount to peers — may indicate relative value. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
14.00%
Dividend Yield
0.14%
More on Remus Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.